Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
ICICI Prudential Nifty Pharma Index Fund Growth
+23.53%
3Y annualised
+1.98% 1D
NAV: 20 Mar '26
₹17.08
Min. for SIP
Not Supported
Fund size
₹97.03 Cr
Expense ratio
1.05%
Holdings (20)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 21.81% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 9.65% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 9.29% |
| Cipla Ltd. | Healthcare | Equity | 8.99% |
| Lupin Ltd. | Healthcare | Equity | 6.62% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 5.37% |
| Laurus Labs Ltd. | Healthcare | Equity | 4.96% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 4.05% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 3.91% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 3.81% |
| Biocon Ltd. | Healthcare | Equity | 3.30% |
| Mankind Pharma Ltd. | Healthcare | Equity | 3.01% |
| Zydus Lifesciences Ltd. | Healthcare | Equity | 2.73% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 2.52% |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 1.99% |
| Gland Pharma Ltd. | Healthcare | Equity | 1.72% |
| Abbott India Ltd. | Healthcare | Equity | 1.64% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 1.50% |
| Wockhardt Ltd. | Healthcare | Equity | 1.33% |
| Piramal Pharma Ltd. | Healthcare | Equity | 1.15% |
See All
Minimum investments
Min. for 1st investment
Not Supported
Min. for 2nd investment
Not Supported
Min. for SIP
Not Supported
Returns and rankings
Annualised returns
Absolute returns
| Name | 6M | 1Y | 3Y | All |
|---|---|---|---|---|
| Fund returns | -0.9% | +5.2% | +23.5% | +17.8% |
| Category average (Equity Sectoral) | +0.2% | -2.1% | +22.1% | -- |
| Rank (Equity Sectoral) | -- | 5 | 10 | -- |
Exit load, stamp duty and tax
Exit load
Nil
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
KEKayzad EghlimNov 2022 - PresentView details
KE
Kayzad Eghlim
Nov 2022 - Present
View details
NPNishit PatelNov 2022 - PresentView details
NP
Nishit Patel
Nov 2022 - Present
View details
AJBAshwini Jemin BharuchaDec 2024 - PresentView details
AJB
Ashwini Jemin Bharucha
Dec 2024 - Present
View details
VAVenus AhujaNov 2025 - PresentView details
VA
Venus Ahuja
Nov 2025 - Present
View details
About ICICI Prudential Nifty Pharma Index Fund Growth
ICICI Prudential Nifty Pharma Index Fund Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 12 Oct 1993. Kayzad Eghlim is the Current Fund Manager of ICICI Prudential Nifty Pharma Index Fund Growth fund. The fund currently has an Asset Under Management(AUM) of ₹11,24,266 Cr and the Latest NAV as of 20 Mar 2026 is ₹17.08.
The ICICI Prudential Nifty Pharma Index Fund Growth is rated Very High risk. Minimum SIP Investment is set to ₹1,000.
;
Investment Objective
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index;
Fund benchmarkNIFTY Pharma Total Return Index
Fund house
Rank (total assets)#3 in India
Total AUM₹11,24,266.03 Cr
Date of Incorporation12 Oct 1993
Launch Date12 Oct 1993
AddressOne BKC , A Wing ,13th Floor, Bandra Kurla Complex, Mumbai 400051
Websitewww.camsonline.com
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,